Lamberto Andreotti was the CEO of Bristol-Myers Squibb Co. from 2010 to 2015. Under his leadership, the company thrived, showcasing strong financial growth. Notably, Andreotti's compensation was largely based on performance. In 2014, he earned a remarkable $8.3 million, driven...
Lamberto Andreotti was the CEO of Bristol-Myers Squibb Co. from 2010 to 2015. Under his leadership, the company thrived, showcasing strong financial growth. Notably, Andreotti's compensation was largely based on performance. In 2014, he earned a remarkable $8.3 million, driven mainly by his bonus for excellent company performance, while he did not receive stock grants or options during his tenure. This reflects a strategy focused on immediate results rather than long-term stock incentives. His career at Bristol-Myers began in 1998, and he worked in various roles including President and COO. After retiring as CEO, he transitioned to Chairman of the Board until 2017. During this time, his personal shares in the company peaked at over $46 million, showcasing a deep financial commitment to the business. Andreotti's career wasn't just about titles; he made impactful decisions that shaped Bristol-Myers into a leader in pharmaceuticals. His history with the company and strategic direction have greatly influenced its growth in the competitive market, setting a strong foundation for future success.